2
Total Mentions
2
Documents
999
Connected Entities
HOUSE_OVERSIGHT_024631 - HOUSE_OVERSIGHT_024816
s a significant development on its own, and one that we believe may signal an important redirection of DEA policy. In October 2017, the FDA accepted GW Pharmaceuticals’ New Drug Application (NDA) for the cannabis-derived drug Epidiolex. The steps required to file an NDA for any drug involve extensive coordination and
Page: HOUSE_OVERSIGHT_024722 →HOUSE_OVERSIGHT_024817 - HOUSE_OVERSIGHT_024922
ormulation of cannabidiol (CBD), Epidiolex, which GW Pharmaceuticals PLC developed for the treatment of seizures associate
the U.S. Census
OrganizationHealthCap
OrganizationBeboe
Organization
Vermont
LocationState of the United States of America

Seattle
LocationCity in and county seat of King County, State of Washington, United States
OrganiGram Holdings Inc.
Organization
Hawaii
LocationState of the United States of America

Uruguay
LocationSovereign state in South America
Teewinot
OrganizationMountain in United States of America

Starbucks
OrganizationAmerican multinational coffee company

United States
LocationCountry located primarily in North America

South Carolina
LocationState of the United States of America

Home Office
OrganizationUnited Kingdom government ministerial department

Portland
LocationSeat of Multnomah County, and largest city in state of Oregon, United States

Oregon
LocationState of the United States of America

Colorado
LocationState of the United States of America

San Diego
LocationSeat of San Diego County, California, United States; second-largest city in California

Indiana
LocationState of the United States of America

Colombia
LocationSovereign state in South America

Minnesota
LocationState of the United States of America